Altar
Altar develops and operates proprietary technologies to commercialize microbes. Altar's customers use microorganisms to make food, fragrances, cosmetics, fuels, chemicals, and health products.
- biotechnology
- horizon europe
- sustainable development goals
- dt and ls
- climate tech
- biotech and pharma
- radar de l'innovation
- tech for business
- observatoire industrial tech
- observatoire deeptech
- alternative protein
- nif defense security and resilience
- tech for biotech and pharma
- eicfund
- fermentation
- nif health crisis preparedness
- microbiology
- agritech and foodtech
- nif biotech
| EUR | 2019 | 2020 | 2021 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| % growth | - | (48 %) | - |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Developer of automated cultivation devices designed to harness natural selection to make better microbes. The company's devices are fully automated and ensure 24/7 permanent proliferation of cell suspensions without contamination for indefinite periods of time through counter-selection of biofilms, enabling industries to improve microorganism performance via natural selection.
Keywords: Pharmaceuticals and Biotechnology, White Biotechnology, Industrial Biotechnology, Industrial Microbial Hosts, Sustainable Industry And Goods, In Vivo Directed Evolution, Adaptive Laboratory Evolution, Natural Selection, Digitalization.